City Therapeutics IPO: Date, Status and What We Know
FiledUnited States · Nasdaq Global MarketCTY
IPO facts
- Status
- Filed
- Market
- United States
- Country
- United States
- Exchange
- Nasdaq Global Market
- Ticker
- CTY
- Sector
- Biotechnology (RNAi therapeutics)
- Filing date
- First trading day
- Not announced
- Price range
- Not announced
- Offering size
- Not announced
- Last valuation
- Not announced
About City Therapeutics
City Therapeutics is a clinical-stage biotechnology company developing RNA interference (RNAi) therapies that silence the expression of disease-relevant proteins.
IPO notes
City Therapeutics publicly filed its Form S-1 on 24 September 2026, after a confidential draft submission. It has applied to list its common stock on the Nasdaq Global Market under CTY; the filing leaves the number of shares and the price range blank (sec.gov). No pricing date had been announced as of 5 October 2026.
Other IPOs in this market
Sources
- sec.gov · Form S-1 registration statement ·
Named as plain text with what each source states and the date it was checked.